Intravenous immunoglobulins for the treatment of childhood autoimmune diseases
Publisher
Springer Vienna
Reference39 articles.
1. Abe Y, Horiuchi A, Masazumi M, Kimura S (1994) Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immunol Rev 139: 5–19
2. Andersson JP, Andersson UG (1990) Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 71: 372–376
3. Arend WP, Leung DYM (1994) IgG induction of IL-1 receptor antagonist production by human monocytes.Immunol Rev 139: 71–78
4. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281: 1305–1308
5. Aukrust P, Froland SS, Liabakk NB, Muller F, Nordoy I, Haug C, Espevik T (1994) Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 84: 2136–2143